BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications Read more
Hovione and Ripple Enter Strategic Partnership to Expand Epidel Platform into Non-Ophthalmic Space Read more
Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP Read more
InvisiShield Technologies Collaborates with Gladstone Institutes to Accelerate Development of Intranasal Preventatives against SARS-CoV-2, Influenza, and RSV Read more
Processa Pharmaceuticals Announces First Patient Dosed in the 300 mg Dose Group with Next Generation Chemotherapy-Capecitabine Read more
Alphamab Oncology Announces the First Patient Dosed in the Phase I Trial of Anti-HER2 bispecific ADC JSKN003 Read more
FDA Approves Expanded Indication for Telix’s Illuccix to Include Patient Selection for PSMA-Directed Radioligand Therapy Read more
Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP Read more
Evotec announces progress in strategic protein degradation partnership with Bristol Myers Squibb Read more
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer Read more